Regimmune Corporation
Organization
Trials
Haplo Peripheral Blood Sct In GVHD Prevention
Collaborator, Phase 1, Completed, 25 people, Jul 16, 2020
Phase 1/2, Completed, 68 people, Jun 23, 2011
Sources: clinicaltrials.gov
Organization
Haplo Peripheral Blood Sct In GVHD Prevention
Collaborator, Phase 1, Completed, 25 people, Jul 16, 2020
Phase 1/2, Completed, 68 people, Jun 23, 2011
Sources: clinicaltrials.gov